Researcher Bios

Learn more about the backgrounds, scientific pursuits and personal interests of the members of our research team. These individuals are committed to pursuing Bristol-Myers Squibb’s goal of discovering, developing and delivering transformational medicines to patients.
Beatrice Anduze-Faris, M.D.
Beatrice Anduze-Faris, M.D.

Head of Global Clinical Compliance & Continuous Improvement, Global Clinical Operations

Michaela Bowden
Michaela Bowden

Director, Translational Biology

Cynthia Brogdon, RN, Ph.D.
Cynthia Brogdon, RN, Ph.D.

Head, Oncology Portfolio Strategy, Oncology Medical

Edgar Charles, M.D.
Edgar Charles, M.D.

Clinical Development Lead, pegylated FGF21

Sharon Cload, Ph. D.
Sharon Cload, Ph. D.

Vice President, Molecular Discovery Technologies

Binodh DeSilva, Ph.D.
Binodh DeSilva, Ph.D.

Head of Analytical and Bioanalytical Operations, Pharmaceutical Development

Melissa Harris, B.Sc, PharmD
Melissa Harris, B.Sc, PharmD

Development Team lead for Fibrosis, Cardiovascular, Fibrosis & Immunoscience

Evan Janovitz
Evan Janovitz, DVM, Ph.D., DACVP

Director of Pathology, Discovery Toxicology 

Emma Lees, Ph.D.
Emma Lees, Ph.D.

Vice President, & Site Head of R&D, Oncology Discovery, Cambridge, MA

Michael May, Ph.D.
Michael May, Ph.D.

Countrywide Medical Director, Germany, Global Medical

Ryan Moslin, Ph.D.
Ryan Moslin, Ph.D.

Senior Research Investigator, Early Immunology Discovery

Mike Quigley, Ph.D.
Mike Quigley, Ph.D.

Vice President and Head, Tumor Microenvironment Modulation Thematic Research Center

Joseph Szustakowski, Ph.D.
Joseph Szustakowski, Ph.D.

Executive Director, Translational Bioinformatics

Saurabh Saha, M.D., Ph.D.
Saurabh Saha, M.D., Ph.D.

SVP, Global Head of Translational Medicine, Cambridge Site Head

John Throup, BSc, Ph.D.
John Throup, BSc, Ph.D.

Development Lead, Immunoscience R&D